Announcement

  • BEMARA declaration, IKF-AIO-BEMARA Phase IIa trial
    EU CT number 2024-512484-31-00
    Download as PDF
Linkedin Instagram Envelope

Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Steinbacher Hohl 2-26
60488 Frankfurt am Main

Copyright © IKF GmbH 2024 all rights reserved